Literature DB >> 18081943

Gamma-tocotrienol-induced apoptosis in human gastric cancer SGC-7901 cells is associated with a suppression in mitogen-activated protein kinase signalling.

Wenguang Sun1, Qi Wang, Bingqing Chen, Jiaren Liu, Huikun Liu, Weili Xu.   

Abstract

Tocotrienols have been shown to inhibit proliferation and induce apoptosis in cancer cells. However, the molecular mechanisms involved in tocotrienol-induced apoptosis are still unclear. In the present study, gamma-tocotrienol induced apoptosis in human gastric adenocarcinoma SGC-7901 cell line through down regulation of the extracellular signal-regulated kinase (ERK) signalling pathway. Furthermore, gamma-tocotrienol-induced apoptosis was accompanied by down regulation of Bcl-2, up regulation of Bax, activation of caspase-3, and subsequent poly (ADP-ribose) polymerase cleavage. These results indicated that up or down regulation of Bcl-2 family proteins play a major role in the initiation of gamma-tocotrienol-induced apoptosis as an activator of caspase-3. Gamma-tocotrienol also down regulated the activation of the Raf-ERK signalling pathway, and down regulated c-Myc by decreasing the expressions of Raf-1 and p-ERK1/2 proteins. The results suggest that key regulators in tocotrienol-induced apoptosis may be Bcl-2 families and caspase-3 in SGC-7901 cells through down regulation of the Raf-ERK signalling pathway.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18081943     DOI: 10.1017/S0007114507879128

Source DB:  PubMed          Journal:  Br J Nutr        ISSN: 0007-1145            Impact factor:   3.718


  17 in total

1.  Tocotrienols fight cancer by targeting multiple cell signaling pathways.

Authors:  Ramaswamy Kannappan; Subash C Gupta; Ji Hye Kim; Bharat B Aggarwal
Journal:  Genes Nutr       Date:  2011-04-09       Impact factor: 5.523

2.  γ-Tocotrienol is a novel inhibitor of constitutive and inducible STAT3 signalling pathway in human hepatocellular carcinoma: potential role as an antiproliferative, pro-apoptotic and chemosensitizing agent.

Authors:  Peramaiyan Rajendran; Feng Li; Kanjoormana Aryan Manu; Muthu K Shanmugam; Ser Yue Loo; Alan Prem Kumar; Gautam Sethi
Journal:  Br J Pharmacol       Date:  2011-05       Impact factor: 8.739

3.  Anti-proliferative effects of γ-tocotrienol are associated with suppression of c-Myc expression in mammary tumour cells.

Authors:  P Parajuli; R V Tiwari; P W Sylvester
Journal:  Cell Prolif       Date:  2015-06-19       Impact factor: 6.831

4.  Why tocotrienols work better: insights into the in vitro anti-cancer mechanism of vitamin E.

Authors:  Valentina Viola; Francesca Pilolli; Marta Piroddi; Elisa Pierpaoli; Fiorenza Orlando; Mauro Provinciali; Michele Betti; Francesco Mazzini; Francesco Galli
Journal:  Genes Nutr       Date:  2011-04-20       Impact factor: 5.523

5.  Metabolism of tocotrienols in animals and synergistic inhibitory actions of tocotrienols with atorvastatin in cancer cells.

Authors:  Zhihong Yang; Mao-Jung Lee; Yang Zhao; Chung S Yang
Journal:  Genes Nutr       Date:  2011-05-18       Impact factor: 5.523

Review 6.  Tocotrienols, the vitamin E of the 21st century: its potential against cancer and other chronic diseases.

Authors:  Bharat B Aggarwal; Chitra Sundaram; Seema Prasad; Ramaswamy Kannappan
Journal:  Biochem Pharmacol       Date:  2010-08-07       Impact factor: 5.858

7.  Troglitazone suppresses c-Myc levels in human prostate cancer cells via a PPARγ-independent mechanism.

Authors:  Tunde O Akinyeke; LaMonica V Stewart
Journal:  Cancer Biol Ther       Date:  2011-06-15       Impact factor: 4.742

Review 8.  Revisiting the therapeutic potential of tocotrienol.

Authors:  Ranmali Ranasinghe; Michael Mathai; Anthony Zulli
Journal:  Biofactors       Date:  2022-06-20       Impact factor: 6.438

Review 9.  Cancer-preventive activities of tocopherols and tocotrienols.

Authors:  Jihyeung Ju; Sonia C Picinich; Zhihong Yang; Yang Zhao; Nanjoo Suh; Ah-Ng Kong; Chung S Yang
Journal:  Carcinogenesis       Date:  2009-09-11       Impact factor: 4.944

10.  γ-Tocotrienol induces paraptosis-like cell death in human colon carcinoma SW620 cells.

Authors:  Jing-Shu Zhang; Da-Ming Li; Yue Ma; Ning He; Qing Gu; Feng-Shan Wang; Shu-Qing Jiang; Bing-Qing Chen; Jia-Ren Liu
Journal:  PLoS One       Date:  2013-02-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.